These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 23692872)

  • 1. Novel nicotinic acetylcholine receptor agonists containing carbonyl moiety as a hydrogen bond acceptor.
    Mazurov AA; Kombo DC; Akireddy S; Murthy S; Hauser TA; Jordan KG; Gatto GJ; Yohannes D
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3927-34. PubMed ID: 23692872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selective α4β2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders.
    Mazurov AA; Miao L; Bhatti BS; Strachan JP; Akireddy S; Murthy S; Kombo D; Xiao YD; Hammond P; Zhang J; Hauser TA; Jordan KG; Miller CH; Speake JD; Gatto GJ; Yohannes D
    J Med Chem; 2012 Nov; 55(21):9181-94. PubMed ID: 22793665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational studies of novel carbonyl-containing diazabicyclic ligands interacting with α4β2 nicotinic acetylcholine receptor (nAChR) reveal alternative binding modes.
    Kombo DC; Mazurov AA; Strachan JP; Bencherif M
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5105-13. PubMed ID: 23937977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).
    Ghiron C; Haydar SN; Aschmies S; Bothmann H; Castaldo C; Cocconcelli G; Comery TA; Di L; Dunlop J; Lock T; Kramer A; Kowal D; Jow F; Grauer S; Harrison B; La Rosa S; Maccari L; Marquis KL; Micco I; Nencini A; Quinn J; Robichaud AJ; Roncarati R; Scali C; Terstappen GC; Turlizzi E; Valacchi M; Varrone M; Zanaletti R; Zanelli U
    J Med Chem; 2010 Jun; 53(11):4379-89. PubMed ID: 20465311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and pharmacological characterization of 3,6-diazabicyclo[3.1.1]heptane-3-carboxamides as novel ligands for the α4β2 and α6/α3β2β3 nicotinic acetylcholine receptors (nAChRs).
    Strachan JP; Kombo DC; Mazurov A; Heemstra R; Bhatti BS; Akireddy R; Murthy S; Miao L; Jett JE; Speake J; Bencherif M
    Eur J Med Chem; 2014 Oct; 86():60-74. PubMed ID: 25147147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen-bond interactions of nicotine and acetylcholine salts: a combined crystallographic, spectroscopic, thermodynamic and theoretical study.
    Arnaud V; Berthelot M; Evain M; Graton J; Le Questel JY
    Chemistry; 2007; 13(5):1499-510. PubMed ID: 17103466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α4β2 neuronal nicotinic receptor positive allosteric modulation: an approach for improving the therapeutic index of α4β2 nAChR agonists in pain.
    Lee CH; Zhu C; Malysz J; Campbell T; Shaughnessy T; Honore P; Polakowski J; Gopalakrishnan M
    Biochem Pharmacol; 2011 Oct; 82(8):959-66. PubMed ID: 21763685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
    Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
    J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary three-dimensional quantitative structure-activity relationship modeling of binding affinity and functional potency: a study on alpha4beta2 nicotinic ligands.
    Tosco P; Ahring PK; Dyhring T; Peters D; Harpsøe K; Liljefors T; Balle T
    J Med Chem; 2009 Apr; 52(8):2311-6. PubMed ID: 19301898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
    Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
    J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
    Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ
    Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nicotinic pharmacophore: thermodynamics of the hydrogen-bonding complexation of nicotine, nornicotine, and models.
    Graton J; Berthelot M; Gal JF; Laurence C; Lebreton J; Le Questel JY; Maria PC; Robins R
    J Org Chem; 2003 Oct; 68(21):8208-21. PubMed ID: 14535805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and affinity profile of novel nicotinic ligands.
    Charton Y; Guillonneau C; Lockhart B; Lestage P; Goldstein S
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2188-93. PubMed ID: 18262785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel α7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogs.
    Kombo DC; Mazurov AA; Chewning J; Hammond PS; Tallapragada K; Hauser TA; Speake J; Yohannes D; Caldwell WS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1179-86. PubMed ID: 22177081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-(2-Aminoethyl)pyridine analogs as alpha4beta2 nicotinic cholinergic receptor ligands.
    Dukat M; Ramunno A; Banzi R; Damaj MI; Martin B; Glennon RA
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4308-12. PubMed ID: 16039854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of linker length alteration of the α7 nicotinic acetylcholine receptor (nAChR) agonist, SEN12333.
    Beinat C; Banister SD; van Prehn S; Doddareddy MR; Hibbs D; Sako M; Chebib M; Tran T; Al-Muhtasib N; Xiao Y; Kassiou M
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2380-4. PubMed ID: 22410083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New ligands with affinity for the alpha4beta2 subtype of nicotinic acetylcholine receptors. Synthesis, receptor binding, and 3D-QSAR modeling.
    Audouze K; Nielsen EØ; Olsen GM; Ahring P; Jørgensen TD; Peters D; Liljefors T; Balle T
    J Med Chem; 2006 Jun; 49(11):3159-71. PubMed ID: 16722635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screening for alpha7 nicotinic acetylcholine receptor for treatment of Alzheimer's disease.
    Chen SG; Gu RX; Dai H; Wei DQ
    J Mol Graph Model; 2013 Feb; 39():98-107. PubMed ID: 23261879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors.
    Bunnelle WH; Daanen JF; Ryther KB; Schrimpf MR; Dart MJ; Gelain A; Meyer MD; Frost JM; Anderson DJ; Buckley M; Curzon P; Cao YJ; Puttfarcken P; Searle X; Ji J; Putman CB; Surowy C; Toma L; Barlocco D
    J Med Chem; 2007 Jul; 50(15):3627-44. PubMed ID: 17585748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.
    Abreo MA; Lin NH; Garvey DS; Gunn DE; Hettinger AM; Wasicak JT; Pavlik PA; Martin YC; Donnelly-roberts DL; Anderson DJ; Sullivan JP; Williams M; Arneric SP; Holladay MW
    J Med Chem; 1996 Feb; 39(4):817-25. PubMed ID: 8632405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.